Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projekte/331-an-open-multicentric-phase-ii-trial-to-evaluate-the-efficacy-and-safety-of-bendamustine-lenalidomide-revlimid-and-dexamethasone-brd-as-2nd-line-therapy-for-patients-with-relapsed-or-refractory-multiple-myeloma